| 1. | | Sophistical Refutations (wikipedia.org) |
| 1 point by aaavl2821 49 days ago | past |
|
| 2. | | Sophist (wikipedia.org) |
| 15 points by aaavl2821 50 days ago | past | 5 comments |
|
| 3. | | Can AI predict clinical trial outcomes? (baybridgebio.com) |
| 2 points by aaavl2821 5 months ago | past |
|
| 4. | | AI won't replace biotech analysts (baybridgebio.com) |
| 1 point by aaavl2821 5 months ago | past |
|
| 5. | | Show HN: Research Pharma Markets with AI (baybridgebio.com) |
| 2 points by aaavl2821 7 months ago | past |
|
| 6. | | Show HN: Search for drugs approved to treat a given disease (baybridgebio.com) |
| 1 point by aaavl2821 9 months ago | past |
|
| 7. | | Better obesity drugs are coming soon (baybridgebio.com) |
| 2 points by aaavl2821 on Oct 8, 2024 | past |
|
| 8. | | The Future of the Obesity Market (baybridgebio.com) |
| 1 point by aaavl2821 on Oct 3, 2024 | past |
|
| 9. | | The obesity drug landscape in one chart (baybridgebio.com) |
| 3 points by aaavl2821 on Aug 15, 2024 | past |
|
| 10. | | A primer on the obesity drug landscape (baybridgebio.com) |
| 2 points by aaavl2821 on Aug 13, 2024 | past |
|
| 11. | | AI-enabled biotech startup analysis (baybridgebio.com) |
| 1 point by aaavl2821 on Oct 30, 2023 | past |
|
| 12. | | Analyzing gene therapy startup in layman's terms (baybridgebio.com) |
| 1 point by aaavl2821 on Oct 27, 2023 | past |
|
| 13. | | AI Analysis of Biotech Startups (baybridgebio.com) |
| 2 points by aaavl2821 on Oct 20, 2023 | past |
|
| 14. | | AI investment analyst: initiating coverage on Neumora Therapeutics (baybridgebio.com) |
| 1 point by aaavl2821 on Oct 5, 2023 | past |
|
| 15. | | Quantifying risk / reward in biotech investing (baybridgebio.com) |
| 1 point by aaavl2821 on Sept 27, 2023 | past |
|
| 16. | | Valuing Biotech Licensing Deals (baybridgebio.com) |
| 1 point by aaavl2821 on July 10, 2023 | past |
|
| 17. | | Show HN: Value Biotech Licensing Deals (baybridgebio.com) |
| 2 points by aaavl2821 on July 6, 2023 | past |
|
| 18. | | Which VCs are still investing in biopharma? (baybridgebio.com) |
| 1 point by aaavl2821 on May 4, 2023 | past |
|
| 19. | | Biotech VC on pace for worst year since 2016 (baybridgebio.com) |
| 2 points by aaavl2821 on May 4, 2023 | past |
|
| 20. | | The biotech venture capital crunch (baybridgebio.com) |
| 1 point by aaavl2821 on April 12, 2023 | past |
|
| 21. | | Show HN: Interactive guide to valuing biotech companies (baybridgebio.com) |
| 2 points by aaavl2821 on March 22, 2023 | past |
|
| 22. | | Diagnosing the problem with biotech R&D (baybridgebio.com) |
| 2 points by aaavl2821 on Sept 21, 2022 | past |
|
| 23. | | Is Biotech Investing Sustainable? (baybridgebio.com) |
| 1 point by aaavl2821 on Sept 8, 2022 | past |
|
| 24. | | The next generation of biotech VCs (baybridgebio.com) |
| 2 points by aaavl2821 on Aug 11, 2022 | past |
|
| 25. | | Will a Recession Save Biotech? (baybridgebio.com) |
| 2 points by aaavl2821 on July 21, 2022 | past |
|
| 26. | | Biotech platforms are out, products are back in (baybridgebio.com) |
| 16 points by aaavl2821 on June 20, 2022 | past | 2 comments |
|
| 27. | | Bargain hunting for biotech stocks [video] (youtube.com) |
| 1 point by aaavl2821 on June 18, 2022 | past |
|
| 28. | | Can big pharma buy every biotech startup? (baybridgebio.com) |
| 1 point by aaavl2821 on June 10, 2022 | past |
|
| 29. | | Biotech crossover investors facing steep losses (baybridgebio.com) |
| 2 points by aaavl2821 on June 7, 2022 | past |
|
| 30. | | Who is still investing in biotech startups? (baybridgebio.com) |
| 2 points by aaavl2821 on May 24, 2022 | past |
|
|
| More |
